4//SEC Filing
Frazier Life Sciences IX, L.P. 4
Accession 0001209191-20-037031
CIK 0001783183other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 5:42 PM ET
Size
16.0 KB
Accession
0001209191-20-037031
Insider Transaction Report
Form 4
Heron Patrick J
10% Owner
Transactions
- Other
Common Stock
2020-06-12−1,456,854→ 5,827,415 total
Holdings
- 12,596(indirect: See footnote)
Common Stock
- 1(indirect: See footnote)
Common Stock
- 3,912(indirect: See footnote)
Common Stock
- 14,937(indirect: See footnote)
Common Stock
FHMLS IX, L.P.
10% Owner
Transactions
- Other
Common Stock
2020-06-12−1,456,854→ 5,827,415 total
Holdings
- 12,596(indirect: See footnote)
Common Stock
- 3,912(indirect: See footnote)
Common Stock
- 14,937(indirect: See footnote)
Common Stock
- 1(indirect: See footnote)
Common Stock
FHMLS IX, L.L.C.
10% Owner
Transactions
- Other
Common Stock
2020-06-12−1,456,854→ 5,827,415 total
Holdings
- 14,937(indirect: See footnote)
Common Stock
- 1(indirect: See footnote)
Common Stock
- 12,596(indirect: See footnote)
Common Stock
- 3,912(indirect: See footnote)
Common Stock
Topper James N
Director
Transactions
- Other
Common Stock
2020-06-12−1,456,854→ 5,827,415 total
Holdings
- 12,596(indirect: See footnote)
Common Stock
- 14,937(indirect: See footnote)
Common Stock
- 1(indirect: See footnote)
Common Stock
- 3,912(indirect: See footnote)
Common Stock
Frazier Life Sciences IX, L.P.
10% Owner
Transactions
- Other
Common Stock
2020-06-12−1,456,854→ 5,827,415 total
Holdings
- 14,937(indirect: See footnote)
Common Stock
- 3,912(indirect: See footnote)
Common Stock
- 1(indirect: See footnote)
Common Stock
- 12,596(indirect: See footnote)
Common Stock
Footnotes (7)
- [F1]Represents a pro rata distribution in-kind by Frazier Life Sciences IX, L.P. ("FLS IX") to its limited partners for no consideration.
- [F2]Represents shares held of record by FLS IX. The general partner of FLS IX is FHMLS IX, L.P., and the general partner of FHMLS IX, L.P. is FHMLS IX, L.L.C. James Topper and Patrick Heron are the sole managing members of FHMLS IX, L.L.C. and share voting and investment power of the securities held by FLS IX. Dr. Topper and Mr. Heron disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.
- [F3]Reflects shares of Common Stock received in the distribution in-kind described herein.
- [F4]Represents shares held of record by FHMLS IX, L.L.C. James Topper and Patrick Heron are the sole managing members of FHMLS IX, L.L.C. and share voting and investment power of the securities held by FLS IX. Dr. Topper and Mr. Heron disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. These shares were previously held through FLS IX.
- [F5]Represents shares held directly by Dr. Topper. These shares were previously held through FLS IX.
- [F6]Represents shares held of record by Topper Group III LLC. Dr. Topper is a manager of Topper Group III LLC and has voting and investment power of the securities held by Topper Group III LLC. These shares were previously held through FLS IX.
- [F7]Represents shares held by The Heron Living Trust 11/30/2004. Mr. Heron is the co-trustee of The Heron Living Trust 11/30/2004 and has voting and investment power of the securities held by The Heron Living Trust 11/30/2004. These shares were previously held through FLS IX.
Documents
Issuer
Phathom Pharmaceuticals, Inc.
CIK 0001783183
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001720320
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 5:42 PM ET
- Size
- 16.0 KB